- Home
- Personal stories
Personal stories
Curing cancer from within: The promise of cell therapy
Harnessing the immune system to target cancer is the goal of a groundbreaking area of oncology research called cell therapy. And Johnson & Johnson is hard at work in the cutting-edge field, aiming to deliver potential new treatment options to people around the world.
How your own DNA could someday save your vision
Imagine living with a genetic disease that could cause blindness in your 40s—and your doctor tells you there are no treatment options. It’s for patients like these that Johnson & Johnson is harnessing cutting-edge technology in the hope of finding real solutions.
Johnson & Johnson award winner David Julius, Ph.D., receives a 2021 Nobel Prize
The company honored him in 2013 with a Dr. Paul Janssen Award for Biomedical Research; now he’s a Nobel Laureate. Learn about the transformational research that’s led to these well-deserved scientific accolades.
How Johnson & Johnson is supporting the next great leaders in mental health
Meet four students dedicated to removing the stigma of mental illness and increasing access to crucial treatments around the world—with the help of the Global Mental Health Scholarship Fund.
Two pioneering RNA scientists win the 2021 Dr. Paul Janssen Award for biomedical research
Learn how their revolutionary work has not only had a crucial impact on the COVID-19 pandemic but is also paving the way for potential future vaccines and treatments.
This nurse leader in Liberia is making sure mothers and babies get the healthcare they need
As Liberia country director for Last Mile Health, Marion Subah is working with the Liberia Ministry of Health to scale and sustain the country’s first national community health worker program.
The power of prioritizing your vision
The idea of sight loss can be scary—but prompt diagnosis by an eye specialist can, in many cases, help preserve vision. For Healthy Vision Month, let these two patient stories inspire you to take action and schedule your checkup.
How drones are being used to deliver lifesaving HIV drugs to remote areas of the world
Normally, in this part of Uganda, medication is delivered by boat—a slow, difficult process. But now a new Johnson & Johnson-supported program is using drones that can serve 20 landing sites across five islands, reaching more than 3,700 people in a single day.
What you need to know about Johnson & Johnson’s 2021 second-quarter earnings
Check out this infographic breakdown of the company’s second-quarter 2021 performance, with key highlights from its Pharmaceutical, Consumer Health and Medical Device businesses.
“1.5 million children are living with HIV in sub-Saharan Africa. I’m one of the doctors treating these young patients every day”
A relaunched Johnson & Johnson partnership will help ensure that many young patients get lifesaving access to HIV medicines. Meet a doctor in Kenya who explains why the program is so crucial.